Contact lens research & innovation, playing sport, moving to Canada from the UK.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 34
- By:
- Publication type:
- Article
Works matching IS 08907080 AND DT 2019 AND VI 11 AND IP 2
Results: 20
1
2
Innovative mobile technology targets low vision: Advancements made in smartphone applications aim to aid visually impaired.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 18
- By:
- Publication type:
- Article
3
Zyloware releases seven new frames for February collection.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 27
- Publication type:
- Article
4
10 tips for the itch.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 25
- Publication type:
- Article
5
FDA approves eye-tracking test to detect concussion.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 23
- Publication type:
- Article
6
The case of the single fixed pupil: Unknown etiology leaves clinician scratching his head.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 22
- By:
- Publication type:
- Article
7
Kenzo collaborates with Thélios of LVMH group.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 30
- Publication type:
- Article
8
B+L launches Zen Multifocal scleral lens for presbyopia.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 17
- Publication type:
- Article
9
A look at the latest and upcoming pharmaceutical patents: Developmental drugs await clinical trial results for public distribution.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 16
- By:
- Publication type:
- Article
10
Choose your words carefully with surgery patients: Clear communication and realistic expectations lead to proper understanding.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 15
- By:
- Publication type:
- Article
11
Intersection of artificial intelligence with epigenetics: Advancements in AI and telemedicine are revolutionizing the optometric field.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 14
- By:
- Publication type:
- Article
12
Eyenovia shares results for MicroStat MIST-1 Phase III mydriasis study.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 13
- Publication type:
- Article
13
Visibly (formerly Opternative) still the same company: Patients don't understand the dangers of skipping an ocular health exam.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 10
- By:
- Publication type:
- Article
14
Poor hand hygiene affects lens wear.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 9
- Publication type:
- Article
15
Optometry Times blogs.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 4
- Publication type:
- Article
16
Editorial Advisory Board.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 3
- By:
- Publication type:
- Article
17
Optometry's role in the opioid epidemic.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 3
- By:
- Publication type:
- Article
18
Essilor forms task force to combat rise of myopia.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 1
- By:
- Publication type:
- Article
19
New CA law affects all VSP providers.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 1
- By:
- Publication type:
- Article
20
Immunomodulators help ocular allergies: Consider this treatment option to offer relief for patients with itch.
- Published in:
- Optometry Times, 2019, v. 11, n. 2, p. 1
- By:
- Publication type:
- Article